A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
Study sponsor: Ocular Therapeutix, Inc. · OCUL
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-12-21Actual
Enrollment · participants65Actual
Source updated2024-04-15Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.